PROSPECT-Lung trial aims to improve treatment for patients with resectable non-small cell lung cancer

The highly anticipated PROSPECT-Lung trial has officially opened, marking a significant step forward in the quest to improve treatment strategies for patients with resectable non-small cell lung cancer.

What is the difference in risk of early prostate cancer death between men at higher vs lower genetic risk?

The risk of early prostate cancer death among men with higher versus lower genetic risk.

July 9, 2024

Merck KGaA’s expanded AI deal; Ascletis has new biomarker data for its PD-L1; Deka closes $20M round

Merck KGaA continues AI-powered deal streak: Merck KGaA has expanded its collaboration with Israeli company Quris-AI, with an eye to identifying liver toxicity risks in

September 30, 2023

DNA-tailored diet could help manage blood glucose and reduce risk of type 2 diabetes progression

A UK trial has found a DNA-tailored diet could help manage blood glucose and reduce risk of progressing to type 2 diabetes in high-risk individuals.

March 7, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.